Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115883) titled 'Bioequivalence study of finerenone tablets' on Jan. 1.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: The Affiliated Panyu Central Hospital, Guangzhou Medical University
Condition:
NA
Intervention:
Fasting test: T-R group:Take the test preparation (T) orally on an empty stomach, swallowing the entire tablet of 20mg (1 tablet) and consuming it with approximately 240mL of warm water. After 3 days, proceed with the crossover administration.
Fasting test: R-T group:Take the reference preparation (R) orally on an empty stomach, swallowing the entire tablet and consuming it with appro...